View Generic ICR - OIRA Conclusion



0584-0523 202208-0584-001
Historical Active 201902-0584-002
USDA/FNS Renewal 2022
Generic Clearance to Conduct Formative Research/CNPP
Revision of a currently approved collection   No
Regular
Approved without change 11/15/2022
Retrieve Notice of Action (NOA) 10/13/2022
This generic ICR umbrella s approved on the understanding that: 1) ICs under this generic clearance will not overlap with ICs under other FNS generic clearances; 2) to the extent that FNS and FDA both conduct studies related to MyPyramid and/or the Dietary Guidelines, FNS and FDA will coordinate their IC activities and share information with each other so as not to duplicate ICs and impose unnecessary burden on the public; 3) respondents will not be asked to respond to these ICs more than quarterly; 4) CNPP will continue to use screening measures when conducting random sampling to ensure that individual members of the public are not included in multiple studies within designated periods of time; 5) because it is unclear if FNS has the statutory authority to provide assurances of confidentiality, FNS will not use the term "confidential" in any materials provided to respondents and will instead use terms like "private to the extent permitted by law"; 6) FNS will submit individual ICs to OMB, along with all necessary supporting statements and burden estimates. OMB will aim to conclude review within 14 days. However, FNS should not assume individual ICs have received OMB approval until FNS has received such approval explicitly, even after 14 days have elapsed.
  Inventory as of this Action Requested Previously Approved
11/30/2025 36 Months From Approved 11/30/2022
174,300 0 174,300
37,065 0 37,065
0 0 0